How recently was a patient with an Anti-streptolysin O (ASO) titer of 426 likely infected with Group A Streptococcus?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 12, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Timing of Group A Streptococcal Infection with ASO Titer of 426

An ASO titer of 426 IU/mL indicates that the patient was likely infected with Group A Streptococcus approximately 3-6 weeks prior to the test.

Understanding ASO Titers and Their Timeline

ASO (Anti-streptolysin O) antibodies follow a specific timeline after Group A Streptococcal infection:

  • ASO titers begin to rise approximately 1 week after infection 1
  • They peak at 3-6 weeks after the initial infection 1
  • Elevated titers may persist for several months after even uncomplicated GAS infections 1

Interpretation of ASO Value of 426 IU/mL

The ASO titer of 426 IU/mL is significantly elevated above normal values:

  • The upper limit of normal (ULN) for adults is typically around 200-240 IU/mL 2, 3
  • A titer of 426 IU/mL represents a value that is approximately twice the upper limit of normal
  • This level strongly suggests a recent GAS infection rather than just a carrier state 1

Clinical Significance and Diagnostic Value

When interpreting this ASO titer:

  • A single elevated ASO titer has limitations in diagnostic accuracy (sensitivity ~66%, specificity ~82%) 4
  • The value of 426 IU/mL is well above the threshold typically used to support the diagnosis of recent streptococcal infection
  • This elevation is consistent with an immunologic response to GAS infection rather than merely a carrier state 1

Factors Affecting Interpretation

Several factors should be considered when interpreting this result:

  • Age: ASO titers tend to be higher in school-aged children and young adults compared to older adults 3
  • Geographic location: Normal values may vary by region (some studies show higher ULN in certain populations) 2
  • Presence of symptoms: The titer should be interpreted in conjunction with clinical presentation
  • Possibility of other streptococcal antibody tests: Anti-DNase B titers may provide additional confirmation 1

Clinical Implications

For a patient with an ASO titer of 426:

  • This finding supports a diagnosis of recent GAS infection within the past 1-2 months
  • If the patient is presenting with symptoms suggestive of post-streptococcal sequelae (such as rheumatic fever or post-streptococcal glomerulonephritis), this titer provides supporting evidence
  • The titer is high enough that it likely represents true infection rather than carrier status 1

Pitfalls and Caveats

  • ASO titers reflect past immunologic events and cannot distinguish between active infection and recent past infection 1
  • A single elevated titer should not be used alone to diagnose active GAS infection
  • Normal levels of antibodies are higher among school-age children than among adults, which can lead to misinterpretation 1
  • Newer ASO tests using different methodologies may not be well standardized against traditional neutralization assays 1

In conclusion, an ASO titer of 426 IU/mL most likely indicates a Group A Streptococcal infection that occurred approximately 3-6 weeks prior to the test, though the elevated level could persist for several months after the initial infection.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.